Free Trial

Connor Clark & Lunn Investment Management Ltd. Has $2.71 Million Holdings in Plexus Corp. $PLXS

Plexus logo with Computer and Technology background

Key Points

  • Connor Clark & Lunn Investment Management Ltd. increased its stake in Plexus Corp. by 139.6% by acquiring 12,318 additional shares, bringing its total to 21,139 shares worth approximately $2.7 million.
  • Plexus Corp. reported $1.90 EPS for the most recent quarter, beating analysts' expectations by $0.19, with revenue of $1.02 billion reflecting a 6.0% year-over-year increase.
  • Insider trading activity included CEO Todd K. Kelsey selling 1,500 shares and CFO Patrick John Jermain selling 2,178 shares recently, indicating potential shifts in executive confidence regarding the stock.
  • Want stock alerts on Plexus? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Connor Clark & Lunn Investment Management Ltd. raised its position in Plexus Corp. (NASDAQ:PLXS - Free Report) by 139.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 21,139 shares of the technology company's stock after purchasing an additional 12,318 shares during the quarter. Connor Clark & Lunn Investment Management Ltd. owned 0.08% of Plexus worth $2,709,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the company. Xponance Inc. raised its position in Plexus by 4.8% in the first quarter. Xponance Inc. now owns 2,315 shares of the technology company's stock valued at $297,000 after purchasing an additional 106 shares during the last quarter. Aquatic Capital Management LLC raised its position in Plexus by 134.0% in the fourth quarter. Aquatic Capital Management LLC now owns 234 shares of the technology company's stock valued at $37,000 after purchasing an additional 134 shares during the last quarter. Squarepoint Ops LLC raised its position in shares of Plexus by 1.1% during the fourth quarter. Squarepoint Ops LLC now owns 13,846 shares of the technology company's stock worth $2,167,000 after acquiring an additional 148 shares during the last quarter. Nisa Investment Advisors LLC raised its position in shares of Plexus by 1.6% during the first quarter. Nisa Investment Advisors LLC now owns 12,773 shares of the technology company's stock worth $1,637,000 after acquiring an additional 205 shares during the last quarter. Finally, Blue Trust Inc. raised its position in shares of Plexus by 49.2% during the first quarter. Blue Trust Inc. now owns 846 shares of the technology company's stock worth $108,000 after acquiring an additional 279 shares during the last quarter. 94.45% of the stock is currently owned by institutional investors.

Plexus Trading Up 0.2%

NASDAQ PLXS traded up $0.32 during trading hours on Tuesday, hitting $131.53. 15,218 shares of the company's stock were exchanged, compared to its average volume of 179,960. The stock has a 50-day simple moving average of $132.56 and a 200 day simple moving average of $130.23. Plexus Corp. has a 1-year low of $103.43 and a 1-year high of $172.89. The firm has a market cap of $3.55 billion, a price-to-earnings ratio of 22.46 and a beta of 0.80. The company has a current ratio of 1.58, a quick ratio of 0.74 and a debt-to-equity ratio of 0.06.

Plexus (NASDAQ:PLXS - Get Free Report) last released its earnings results on Wednesday, July 23rd. The technology company reported $1.90 EPS for the quarter, topping the consensus estimate of $1.71 by $0.19. Plexus had a return on equity of 12.33% and a net margin of 4.04%.The business had revenue of $1.02 billion during the quarter, compared to analysts' expectations of $1.02 billion. During the same quarter last year, the firm posted $1.45 earnings per share. The firm's revenue was up 6.0% on a year-over-year basis. Plexus has set its Q4 2025 guidance at 1.820-1.970 EPS. On average, equities analysts forecast that Plexus Corp. will post 5.9 EPS for the current fiscal year.

Insider Transactions at Plexus

In other Plexus news, CEO Todd P. Kelsey sold 1,500 shares of the firm's stock in a transaction that occurred on Friday, August 1st. The stock was sold at an average price of $125.63, for a total value of $188,445.00. Following the completion of the sale, the chief executive officer owned 72,214 shares of the company's stock, valued at approximately $9,072,244.82. This trade represents a 2.03% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Patrick John Jermain sold 2,178 shares of the firm's stock in a transaction that occurred on Wednesday, August 6th. The shares were sold at an average price of $130.42, for a total value of $284,054.76. Following the completion of the sale, the chief financial officer directly owned 23,459 shares of the company's stock, valued at $3,059,522.78. This trade represents a 8.50% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 11,382 shares of company stock valued at $1,482,171. Company insiders own 1.76% of the company's stock.

Analysts Set New Price Targets

PLXS has been the subject of a number of analyst reports. Sidoti upgraded Plexus from a "neutral" rating to a "buy" rating and raised their price objective for the stock from $135.00 to $150.00 in a research report on Friday, July 25th. Stifel Nicolaus set a $140.00 price objective on Plexus in a research report on Thursday, July 24th. Needham & Company LLC lowered their price objective on Plexus from $162.00 to $158.00 and set a "buy" rating for the company in a research report on Thursday, July 24th. Benchmark restated a "buy" rating and set a $160.00 price objective on shares of Plexus in a research report on Wednesday, June 4th. Finally, Wall Street Zen downgraded Plexus from a "strong-buy" rating to a "buy" rating in a research report on Saturday. Three equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $152.00.

View Our Latest Analysis on Plexus

About Plexus

(Free Report)

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

Featured Articles

Institutional Ownership by Quarter for Plexus (NASDAQ:PLXS)

Should You Invest $1,000 in Plexus Right Now?

Before you consider Plexus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.

While Plexus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines